The Purpose of This Study is to Evaluate New Commercially Available Magnetic Resonance (MR) Imaging Sequence and/or Hardware

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011 by State University of New York - Upstate Medical University.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
State University of New York - Upstate Medical University
ClinicalTrials.gov Identifier:
NCT00640107
First received: March 12, 2008
Last updated: February 24, 2011
Last verified: February 2011
  Purpose

Magnetic Resonance Imaging (MRI) is a non-invasive diagnostic imaging technology that produces images of the body. This technology does not utilize radiation, as does Computed Tomography (CT) but relies on radio waves and a strong magnet to produce images.

The purpose of this study is to evaluate new commercially available MR imaging sequence and/or hardware that have been installed on an existing MR unit or to evaluate a new MR unit. The study also serves to familiarize the MR technical staff with how to operate the new equipment. The information obtained will be used to optimize new MR equipment that has been installed on the MR scanner


Condition
Healthy

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Evaluation and Optimization of New MRI Hardware and Software in Existing SUNY MRI Units and Newly Installed Commercially Available Units.

Further study details as provided by State University of New York - Upstate Medical University:

Estimated Enrollment: 30
Study Start Date: October 2006
Detailed Description:

Magnetic Resonance Imaging (MRI) has been utilized for 20 years as a clinical and research tool at SUNY Upstate Medical University. Currently, there are five (5) MR (1 low-field 0.2 Tesla, 3 high-field 1.5 Tesla and 1 3.0 Tesla) units in use on the university campus. During this time, new imaging sequences and hardware including smaller more powerful magnets and faster computers have been developed that assist in the diagnosis of many disease processes. MR Angiography, MR Spectroscopy, diffusion weighted imaging and a dedicated combination Neurovascular head and neck coil are just several of the many imaging sequences and specialized coils that have been developed over the last several years.

New imaging sequences and hardware including 4.0 and 7.0 Tesla magnets are currently undergoing development and testing at several universities in the United States and worldwide. As a consequence of the many new innovations in MR imaging we must periodically upgrade our existing MR units and on occasion replace one of our existing MR units or purchase a new MR unit. This will ensure that we have the most up to date MR equipment to provide state of the art diagnostic imaging capabilities at University Hospital. The new imaging sequences and/or hardware must be optimized for each MR unit to achieve the highest signal to noise (SNR) and contrast to noise (CNR) ratios in a reasonable scan time. This practice is routinely performed at every university and private hospital as well as outpatient imaging center when a new MR unit is installed and when an existing unit is upgraded

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

any subjects willing to undergo an MRI

Criteria

Inclusion Criteria:

  • Able to understand and sign informed consent

Exclusion Criteria:

  • Subject who is > 300 pounds
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00640107

Locations
United States, New York
SUNY Upstate Medical University
Syracuse, New York, United States, 13210
Sponsors and Collaborators
State University of New York - Upstate Medical University
Investigators
Principal Investigator: Kent Ogden, PhD State University of New York - Upstate Medical University
  More Information

No publications provided

Responsible Party: Kent Ogden, Ph.D., SUNY Upstate Medical University
ClinicalTrials.gov Identifier: NCT00640107     History of Changes
Other Study ID Numbers: SUNYUMU 5431
Study First Received: March 12, 2008
Last Updated: February 24, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by State University of New York - Upstate Medical University:
Magnetic Resonance Imaging

ClinicalTrials.gov processed this record on September 22, 2014